Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-07

Clinical Trial Update: Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a milk product enriched with anthocyans, calcium, and vitamin D for osteoporosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osteoprotector milk product based on anthocyans and enriched in calcium and vitamin D

Snippet

Sponsor: Elvir SAS | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED